The CHI3L1-neutrophil axis drives immune suppression and breast cancer metastatic dissemination
JCI Insight · 23.03.2026 · 11 (6)
DOI: 10.1172/jci.insight.199307 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 03.02.2026. Verfasst von Tarek Taifour und 20 weiteren Autor:innen. Beteiligte Einrichtung: McGill University, Division of Experimental Medicine, Department of Medicine, Faculty of Medicine, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Chitinase-3-Like Protein 1, Neutrophils, Breast Neoplasms, Lung Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Terry Fox Research Institute Program Group Grant, Canadian Cancer Society Impact Grant, Canadian Institute of Health Research.
Abstract (Originalsprache)
Immunosuppression and metastasis are critical hallmarks of breast cancer, often linked to poor patient outcomes. The secreted cytokine chitinase-3–like 1 (CHI3L1) is frequently overexpressed in breast cancer samples and promotes an immunosuppressed tumor microenvironment. Notably, CHI3L1 expression is elevated in metastatic patient samples when compared with the matched primary breast tumor. To investigate its role in breast cancer metastasis, we generated an inducible genetically engineered mouse model that overexpresses CHI3L1 in the mammary epithelium. Ectopic expression of CHI3L1 in the polyomavirus middle T (PyMT) mouse model of breast cancer suppressed antitumor immune responses, accelerated mammary tumor onset, and enhanced lung metastasis. Mechanistically, elevated CHI3L1 expression in the mammary epithelium enhanced neutrophil recruitment, which subsequently degraded the extracellular matrix and increased the number of circulating tumor cells. These findings reveal a key mechanism driving metastatic dissemination and argue that therapeutically targeting Chi3l1 could enhance antitumor immunity and suppress metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- McGill University, Division of Experimental Medicine, Department of Medicine, Faculty of Medicine, Montreal, Quebec, Canada.
- Rosalind and Morris Goodman Cancer Institute, Montreal, Quebec, Canada.
- McGill University, Department of Biochemistry, Faculty of Medicine, Montreal, Quebec, Canada.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
- Brown University, Molecular Biology and Immunology, Providence, Rhode Island, USA.
- Hanyang University, Intercollege, Seoul, South Korea.
Förderung
- Terry Fox Research Institute Program Group Grant
- Canadian Cancer Society Impact Grant
- Canadian Institute of Health Research
- Cancer Research Society
Zitieren
APA
Taifour, T., Massé, A., Gu, Y., Sanguin-Gendreau, V., Zuo, D., Xiao, B., Solymoss, E., Shen, Y., Proud, H., Attalla, S. S., Papavasiliou, V., Lin, N. U., Hughes, M. E., Smith, K., Lee, C. G., Kamle, S., Ursini-Siegel, J., Elias, J. A., Siegel, P. M., …, & Muller, W. J. (2026). The CHI3L1-neutrophil axis drives immune suppression and breast cancer metastatic dissemination. JCI Insight, 11(6). https://doi.org/10.1172/jci.insight.199307
Vancouver
Taifour T, Massé A, Gu Y, Sanguin-Gendreau V, Zuo D, Xiao B, et al. The CHI3L1-neutrophil axis drives immune suppression and breast cancer metastatic dissemination. JCI Insight. 2026;11(6). doi:10.1172/jci.insight.199307
BibTeX
@article{Taifour2026,
author = {Taifour, Tarek and Massé, Adéline and Gu, Yu and Sanguin-Gendreau, Virginie and Zuo, Dongmei and Xiao, Bin and Solymoss, Emilie and Shen, Yunyun and Proud, Hailey and Attalla, Sherif Samer and Papavasiliou, Vasilios and Lin, Nancy U and Hughes, Melissa E and Smith, Kalie and Lee, Chun Geun and Kamle, Suchitra and Ursini-Siegel, Josie and Elias, Jack A and Siegel, Peter M and Jeselsohn, Rinath and Muller, William J},
title = {The CHI3L1-neutrophil axis drives immune suppression and breast cancer metastatic dissemination},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {6},
doi = {10.1172/jci.insight.199307}
}
EUVIMED